Jana Skřičková

3.9k total citations
80 papers, 869 citations indexed

About

Jana Skřičková is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Jana Skřičková has authored 80 papers receiving a total of 869 indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Pulmonary and Respiratory Medicine, 31 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Jana Skřičková's work include Lung Cancer Treatments and Mutations (30 papers), Lung Cancer Research Studies (19 papers) and Lung Cancer Diagnosis and Treatment (15 papers). Jana Skřičková is often cited by papers focused on Lung Cancer Treatments and Mutations (30 papers), Lung Cancer Research Studies (19 papers) and Lung Cancer Diagnosis and Treatment (15 papers). Jana Skřičková collaborates with scholars based in Czechia, Greece and United States. Jana Skřičková's co-authors include Milada Zemanová, Miloš Pešek, Vı́tězslav Kolek, Martina Doubková, Libor Havel, Petr Průša, Luboš Petruželka, Petr Zatloukal, František Foret and Petr Kubáň and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Analytical Chemistry.

In The Last Decade

Jana Skřičková

65 papers receiving 843 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jana Skřičková Czechia 17 431 373 218 93 80 80 869
Tamio Okimoto Japan 15 203 0.5× 168 0.5× 210 1.0× 98 1.1× 84 1.1× 50 643
Marko Jakopović Croatia 16 402 0.9× 262 0.7× 234 1.1× 133 1.4× 183 2.3× 93 937
Yukari Tsubata Japan 14 281 0.7× 247 0.7× 152 0.7× 57 0.6× 59 0.7× 101 612
Anne Fajac France 17 224 0.5× 257 0.7× 274 1.3× 58 0.6× 138 1.7× 40 834
Takuo Shibayama Japan 18 812 1.9× 687 1.8× 318 1.5× 41 0.4× 179 2.2× 112 1.3k
Nadia Yousaf United Kingdom 18 400 0.9× 619 1.7× 182 0.8× 92 1.0× 98 1.2× 48 1.2k
Masao Ichiki Japan 15 273 0.6× 369 1.0× 196 0.9× 39 0.4× 112 1.4× 47 622
Paul J. McMurrick Australia 18 252 0.6× 605 1.6× 135 0.6× 110 1.2× 40 0.5× 55 1.2k
Kalliopi Domvri Greece 15 308 0.7× 156 0.4× 143 0.7× 55 0.6× 33 0.4× 46 643

Countries citing papers authored by Jana Skřičková

Since Specialization
Citations

This map shows the geographic impact of Jana Skřičková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jana Skřičková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jana Skřičková more than expected).

Fields of papers citing papers by Jana Skřičková

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jana Skřičková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jana Skřičková. The network helps show where Jana Skřičková may publish in the future.

Co-authorship network of co-authors of Jana Skřičková

This figure shows the co-authorship network connecting the top 25 collaborators of Jana Skřičková. A scholar is included among the top collaborators of Jana Skřičková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jana Skřičková. Jana Skřičková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Skřičková, Jana, Libor Havel, Leona Koubková, et al.. (2023). Effectiveness of first-line anticancer treatment may predict treatment response in further lines in stage III/IV patients with non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology. 149(19). 17123–17131. 1 indexed citations
2.
Marel, Miloslav, Jana Skřičková, Libor Havel, et al.. (2022). Worse Prognosis in the Symptomatic Patients With Lung Cancer – Czech Multicentric Study. Cancer Diagnosis & Prognosis. 2(2). 167–172.
3.
Brat, Kristián, Jana Skřičková, Miloš Pešek, et al.. (2020). Real‐life effectiveness of first‐line anticancer treatments in stage IIIB/IV NSCLC patients: Data from the Czech TULUNG Registry. Thoracic Cancer. 11(11). 3346–3356. 7 indexed citations
4.
Svatoň, Martin, Milada Zemanová, Juraj Kultan, et al.. (2020). Impact of Concomitant Medication Administered at the Time of Initiation of Nivolumab Therapy on Outcome in Non-small Cell Lung Cancer. Anticancer Research. 40(4). 2209–2217. 68 indexed citations
5.
Greguš, Michal, Jana Skřičková, Martina Doubková, et al.. (2019). Capillary electrophoretic analysis of ionic content in exhaled breath condensate and pH monitoring as a non-invasive method in gastroesophageal reflux disease diagnostics. Journal of Chromatography B. 1134-1135. 121857–121857. 8 indexed citations
6.
Skřičková, Jana, Miloš Pešek, Vı́tězslav Kolek, et al.. (2019). Non-small Cell Lung Cancer as a Chronic Disease – A Prospective Study from the Czech TULUNG Registry. In Vivo. 34(1). 369–379. 8 indexed citations
7.
Doubková, Martina, Martina Šterclová, Martina Plačková, et al.. (2017). [Idiopathic pulmonary fibrosis prognostic factors - analysis of the Czech registry].. PubMed. 155(4). 22–8. 4 indexed citations
8.
Skřičková, Jana, et al.. (2015). Accuracy Analysis of Narrow Band Imaging (NBI) Bronchoscopy Compared To White Light Bronchoscopy in the Diagnostics of Lung Tumours.. International Journal of Health Sciences and Research. 5(6). 80–88. 1 indexed citations
9.
Doubková, Martina, Mojmír Moulis, & Jana Skřičková. (2015). [Interstitial lung diseases and granulomatoses associated common variable immunodeficiency].. PubMed. 61(2). 119–24. 2 indexed citations
10.
Skřičková, Jana, et al.. (2014). The prevalence of obstructive sleep apnea in patients hospitalized for COPD exacerbation. Biomedical Papers. 159(3). 422–428. 32 indexed citations
11.
Doubková, Martina, et al.. (2014). Prognostic significance of selected biomarkers in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease. European Respiratory Journal. 44(Suppl 58). P471–P471. 1 indexed citations
12.
13.
Skřičková, Jana, et al.. (2012). Přehled dechových pomůcek pro hygienu dýchacích cest v praxi. 9(5). 250–255.
14.
Skřičková, Jana, et al.. (2011). Biologická léčba nemalobuněčného karcinomu plic. Interní medicína pro praxi. 13(5). 292–295. 1 indexed citations
15.
Doubková, Martina & Jana Skřičková. (2010). Dušnost ve stáří podmíněná onemocněním plic. 3–6. 1 indexed citations
16.
Pirker, Robert, Stephen Brincat, Peter Kasan, et al.. (2010). Therapy of small cell lung cancer with emphasis on oral topotecan. Lung Cancer. 70(1). 7–13. 12 indexed citations
17.
Skřičková, Jana, et al.. (2009). Nutritional risk screening predicts tumor response in lungcancer patients. Journal of Thoracic Oncology. 4(9). 1 indexed citations
18.
Skřičková, Jana, et al.. (2006). [Non-invasive ventilation support in patients with acute exacerbation of chronic obstructive pulmonary disease (COPD)].. PubMed. 52(3). 241–8. 8 indexed citations
19.
Zatloukal, Petr, Luboš Petruželka, Milada Zemanová, et al.. (2003). Gemcitabine plus Cisplatin versus Gemcitabine plus Carboplatin in Stage IIIb and IV Non Small Lung Cancer: A phase III Randomized Trial. Lung Cancer. 41. 41 indexed citations
20.
Skřičková, Jana, et al.. (2001). A realistic view of the treatment of non-small cell lung cancer(NSCLC): an analysis of 348 consecutive patients. 47–47. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tamio Okimoto Breakdown of academic impact, for papers by Marko Jakopović Breakdown of academic impact, for papers by Yukari Tsubata Breakdown of academic impact, for papers by Anne Fajac Breakdown of academic impact, for papers by Takuo Shibayama Breakdown of academic impact, for papers by Nadia Yousaf Breakdown of academic impact, for papers by Masao Ichiki Breakdown of academic impact, for papers by Paul J. McMurrick Breakdown of academic impact, for papers by Kalliopi Domvri
Rankless by CCL
2026